These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of hippocampal 5-HT1A receptors in the antidepressant-like phenotype of mice expressing RGS-insensitive Gαi2 protein. Senese NB; Oginsky M; Neubig RR; Ferrario C; Jutkiewicz EM; Traynor JR Neuropharmacology; 2018 Oct; 141():296-304. PubMed ID: 30189184 [TBL] [Abstract][Full Text] [Related]
3. Regulator of G-protein signaling 6 (RGS6) promotes anxiety and depression by attenuating serotonin-mediated activation of the 5-HT(1A) receptor-adenylyl cyclase axis. Stewart A; Maity B; Wunsch AM; Meng F; Wu Q; Wemmie JA; Fisher RA FASEB J; 2014 Apr; 28(4):1735-44. PubMed ID: 24421401 [TBL] [Abstract][Full Text] [Related]
4. 5-HT1A receptor-mediated phosphorylation of extracellular signal-regulated kinases (ERK1/2) is modulated by regulator of G protein signaling protein 19. Wang Q; Terauchi A; Yee CH; Umemori H; Traynor JR Cell Signal; 2014 Sep; 26(9):1846-52. PubMed ID: 24793302 [TBL] [Abstract][Full Text] [Related]
5. The role of activation of the 5-HT1A receptor and adenylate cyclase in the antidepressant-like effect of YL-0919, a dual 5-HT1A agonist and selective serotonin reuptake inhibitor. Qin JJ; Chen HX; Zhao N; Yuan L; Zhang YZ; Yang RF; Zhang LM; Li YF Neurosci Lett; 2014 Oct; 582():104-8. PubMed ID: 25220701 [TBL] [Abstract][Full Text] [Related]
6. Rapid reorganization of serotonin projections and antidepressant response to 5-HT1A-biased agonist NLX-101 in fluoxetine-resistant cF1ko mice. Vahid-Ansari F; Newman-Tancredi A; Fuentes-Alvarenga AF; Daigle M; Albert PR Neuropharmacology; 2024 Dec; 261():110132. PubMed ID: 39208980 [TBL] [Abstract][Full Text] [Related]
7. Isoflurane-induced changes in righting response and breathing are modulated by RGS proteins. Icaza EE; Huang X; Fu Y; Neubig RR; Baghdoyan HA; Lydic R Anesth Analg; 2009 Nov; 109(5):1500-5. PubMed ID: 19843788 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output. van Amsterdam C; Seyfried CA Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272 [TBL] [Abstract][Full Text] [Related]
9. Loss of Adult 5-HT1A Autoreceptors Results in a Paradoxical Anxiogenic Response to Antidepressant Treatment. Turcotte-Cardin V; Vahid-Ansari F; Luckhart C; Daigle M; Geddes SD; Tanaka KF; Hen R; James J; Merali Z; Béïque JC; Albert PR J Neurosci; 2019 Feb; 39(8):1334-1346. PubMed ID: 30552180 [TBL] [Abstract][Full Text] [Related]
10. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat. De Vry J; Schreiber R; Melon C; Dalmus M; Jentzsch KR Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388 [TBL] [Abstract][Full Text] [Related]
11. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors. Tordera RM; Monge A; Del Río J; Lasheras B Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683 [TBL] [Abstract][Full Text] [Related]
12. Gα(i2)-mediated protection from ischaemic injury is modulated by endogenous RGS proteins in the mouse heart. Waterson RE; Thompson CG; Mabe NW; Kaur K; Talbot JN; Neubig RR; Rorabaugh BR Cardiovasc Res; 2011 Jul; 91(1):45-52. PubMed ID: 21349876 [TBL] [Abstract][Full Text] [Related]
13. Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice. Guilloux JP; David DJ; Guiard BP; Chenu F; Repérant C; Toth M; Bourin M; Gardier AM Neuropsychopharmacology; 2006 Oct; 31(10):2162-72. PubMed ID: 16452992 [TBL] [Abstract][Full Text] [Related]
14. Antidepressant-like activity of YL-0919: a novel combined selective serotonin reuptake inhibitor and 5-HT1A receptor agonist. Chen HX; Jin ZL; Zhang LM; Xue R; Xu XD; Zhao N; Qiu ZK; Wang XW; Zhang YZ; Yang RF; Li YF PLoS One; 2013; 8(12):e83271. PubMed ID: 24367588 [TBL] [Abstract][Full Text] [Related]
15. Pleiotropic phenotype of a genomic knock-in of an RGS-insensitive G184S Gnai2 allele. Huang X; Fu Y; Charbeneau RA; Saunders TL; Taylor DK; Hankenson KD; Russell MW; D'Alecy LG; Neubig RR Mol Cell Biol; 2006 Sep; 26(18):6870-9. PubMed ID: 16943428 [TBL] [Abstract][Full Text] [Related]
16. Resistance to diet-induced obesity and improved insulin sensitivity in mice with a regulator of G protein signaling-insensitive G184S Gnai2 allele. Huang X; Charbeneau RA; Fu Y; Kaur K; Gerin I; MacDougald OA; Neubig RR Diabetes; 2008 Jan; 57(1):77-85. PubMed ID: 17928396 [TBL] [Abstract][Full Text] [Related]
17. Neurochemical and behavioural effects of hypidone hydrochloride (YL-0919): a novel combined selective 5-HT reuptake inhibitor and partial 5-HT Zhang LM; Wang XY; Zhao N; Wang YL; Hu XX; Ran YH; Liu YQ; Zhang YZ; Yang RF; Li YF Br J Pharmacol; 2017 May; 174(9):769-780. PubMed ID: 27882537 [TBL] [Abstract][Full Text] [Related]
18. Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A receptor in modulating anxiety-related behaviors. Zhang J; Huang XY; Ye ML; Luo CX; Wu HY; Hu Y; Zhou QG; Wu DL; Zhu LJ; Zhu DY J Neurosci; 2010 Feb; 30(7):2433-41. PubMed ID: 20164327 [TBL] [Abstract][Full Text] [Related]
19. Expression of the 5-HT1A serotonin receptor in the hippocampus is required for social stress resilience and the antidepressant-like effects induced by the nicotinic partial agonist cytisine. Mineur YS; Einstein EB; Bentham MP; Wigestrand MB; Blakeman S; Newbold SA; Picciotto MR Neuropsychopharmacology; 2015 Mar; 40(4):938-46. PubMed ID: 25288485 [TBL] [Abstract][Full Text] [Related]
20. Effects of the potential antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone monomethanesulfonate] a combined sigma and 5-HT1A ligand: modulation of neuronal activity in the dorsal raphe nucleus. Bermack JE; Haddjeri N; Debonnel G J Pharmacol Exp Ther; 2004 Aug; 310(2):578-83. PubMed ID: 15044555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]